14-May-13 Webinar: Proven Strategies for Rare Disease and Orphan Drug Development in Europe
At Premier Research, we focus on doing what we do best: on helping highly innovative biopharmaceutical and medical device companies bring their life-changing developments from initial strategy through clinical development to…Learn More
Orphan Drug Congress: Part 3
Making Rare Disease Trials Feasible: Trial Implementation
Events
19-May-13 Spring 2013 Forum on Optimizing Clinical Research Performance
24-Jun-13 EFGCP Workshop on: A Practical Approach to Risk-Based Monitoring
24-Jun-13 DIA Annual Meeting
10-Sep-13 SCDM Annual Conference
One thousand people anticipating the unexpected. Global clinical research. It's what we do. Best.
Past Presentations
2012
Modelling Dosing Design in Oracle Clinical2012
Paper Case Report Form Design Tools2012
Blinded Pre-testing of an Oracle Clinical Study Closeout Using a Development Instance
Orphan Drug Congress: Part 2
Regulatory Landscape: Making Rare Disease Trials Feasible
Three times as many medical device studies as the world’s largest CRO. Learn More
We worked on 600+ trials for virtually every major class of analgesic, enrolling 90,000+ patients. Learn More
Be part of the latest advances in healthcare. Join our clinical investigator database. Learn More
Physicians—find out how to make clinical research part of your practice. Learn More
Being a clinical investigator will provide you with access to the latest advancements in medicine. Learn More
Orphan Drug Congress: Part 4
Making Rare Disease Trials Feasible: Logistics and Costs
20+LocationsNorth America,
Western, Central and Eastern Europe
Featured Experts
With a network of skilled staff operating in more than 30 countries, Premier Research is able to manage large global trials and programs.
Susan Tansey
United Kingdom
Featured
Expert
United Kingdom
Medical Director, Pediatrics
Dr. Tansey, MBCHB, MRCP, CCST, is an expert in developing detailed clinical development strategies for companies in the pediatric therapeutic field.
Colin R. W. Hayward
United Kingdom
Featured
Expert
United Kingdom
VP, Medical Affairs
Colin R. W. Hayward, MD, FFPM, is a board certified pharmaceutical physician with more than 12 years international experience in pharmacovigilance, design and implementation of clinical programs and medical affairs.
Michael H. Skinner
Salt Lake City
Featured
Expert
Salt Lake City
Executive Director, Global Medical Affairs and Strategic Consulting
Michael H. Skinner, MD, PharmD, provides consulting, strategic development and medical monitoring services for clinical programs involving analgesia, neurology, psychiatry, medical devices, and other medical products.
Michael Kuss
Austin
Featured
Expert
Austin
Vice President, Analgesia
Mr. Michael Kuss is Premier Research’s therapeutic leader in analgesia and rheumatology. He is also responsible for strategic, commercial, organizational and financial aspects of our Clinical Research Centers, which specialize in Phase I trials.
Etienne Drouet
Spain
Featured
Expert
Spain
Executive Director, Oncology
Mr. Drouet plays a leading role in the operations, strategic planning and corporate development of Premier Research’s growing portfolio of oncology business.
Charlene Sanders
Philadelphia
Featured
Expert
Philadelphia
Vice President Regulatory Affairs and Pediatric Strategic Consulting
Dr. Sanders, MD, FAAP, has provided senior level FDA and global regulatory and clinical development input, expertise and oversight for research progression, compilation, submission of INDs, pre-NDA documents, clinical research protocols and NDAs for products in various therapeutic areas.
Angi Robinson
Austin
Featured
Expert
Austin
Executive Director, Pediatrics and Rare Diseases
Angi Robinson, BS, has been conducting global trials in pediatrics and rare diseases for more than ten years at Premier Research.
Germany
Clinical Research Expertise from Around the Globe
Our extensive network enables us to apply local knowledge and expertise to international projects. Our broad operational footprint allows many options for subject enrollment and enables access to diverse patient populations. Learn More
From 2008 through 2012 Premier Research conducted 60% of their clinical trials in North America and 40% throughout Europe.
